<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20980500</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>01</Month>
            <Day>20</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>85</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7.</ArticleTitle>
            <Pagination>
                <MedlinePgn>178-88</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00998-10</ELocationID>
            <Abstract>
                <AbstractText>The genus β human papillomavirus (HPV) type 8 is associated with nonmelanoma skin cancer in patients with epidermodysplasia verruciformis, and evidence for its protumorigenic potential in the general population increases. To date, strategies to suppress genus β HPV infections are limited. Interferon regulatory factors IRF-3 and IRF-7 play key roles in the activation of the innate immune response to viral infections. In this study, we show for the first time that both IRF-3 and IRF-7 regulate transcription of a papillomavirus, but with opposing effects. IRF-7, expressed in the suprabasal layers of human epidermis, increased HPV8 late promoter activity via direct binding to viral DNA. UV-B light-induced activation of the HPV8 promoter involved IRF-7 as a downstream effector. In contrast, IRF-3, expressed in all layers of human epidermis, induced strong HPV8 suppression in primary keratinocytes. IRF-3-mediated suppression prevailed over IRF-7-induced HPV8 transcription. Unlike the E6 oncoprotein of the mucosal high-risk HPV16, the HPV8 E6 protein did not bind to IRF-3 and only weakly antagonized its activity. Strong antiviral activity was also observed, when keratinocytes were treated with potent IRF-3 activators, poly(I:C) or RNA bearing 5' phosphates. In conclusion, we show that IRF-3 activation induces a state of cell-autonomous immunity against HPV in primary human keratinocytes. Our study suggests that local application of IRF-3-activating compounds might constitute an attractive novel therapeutic strategy against HPV8-associated diseases, particularly in epidermodysplasia verruciformis patients.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Oldak</LastName>
                    <ForeName>Monika</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Virology, Saarland University, Kirrbergerstrasse, Building 47, 66421 Homburg/Saar, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tolzmann</LastName>
                    <ForeName>Liv</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wnorowski</LastName>
                    <ForeName>Artur</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Podgórska</LastName>
                    <ForeName>Marta Justyna</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Silling</LastName>
                    <ForeName>Steffi</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Rongtuan</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hiscott</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Müller</LastName>
                    <ForeName>Cornelia Sigrid Lissi</ForeName>
                    <Initials>CS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vogt</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smola</LastName>
                    <ForeName>Hans</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smola</LastName>
                    <ForeName>Sigrun</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C494232">IRF3 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D050839">Interferon Regulatory Factor-7</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D052686" MajorTopicYN="N">Betapapillomavirus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015967" MajorTopicYN="Y">Gene Expression Regulation, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050838" MajorTopicYN="N">Interferon Regulatory Factor-3</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050839" MajorTopicYN="N">Interferon Regulatory Factor-7</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015603" MajorTopicYN="N">Keratinocytes</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014158" MajorTopicYN="Y">Transcription, Genetic</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20980500</ArticleId>
            <ArticleId IdType="pii">JVI.00998-10</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.00998-10</ArticleId>
            <ArticleId IdType="pmc">PMC3014176</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Virol. 2005 Jan;150(1):145-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15654507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2005 Feb;79(3):1724-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15650197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2005 Sep;79(18):11671-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16140744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cutan Med Surg. 2004 Sep-Oct;8(5):357-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15868315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2010 Feb;84(3):1376-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19923172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2009 Dec;90(Pt 12):2855-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19692543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2006 Apr 13;440(7086):949-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16612387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2000 Mar 10;275(10):6764-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10702232</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2000 Mar 1;60(5):1153-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10728664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2000 May 15;164(10):5352-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10799898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Med. 2000 Jun;5(6):661-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10812019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2000 Sep;20(17):6342-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10938111</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2000 Nov 3;275(44):34320-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10893229</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine Growth Factor Rev. 2001 Jun-Sep;12(2-3):157-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11325599</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2001 Nov 9;276(45):41629-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11473119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2003 May;77(9):5253-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12692227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst Monogr. 2003;(31):52-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12807946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2003 Sep;77(17):9359-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12915551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2004 Oct;78(19):10738-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15367640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1992 Jun;66(6):3485-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1316464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1993 Nov 1;53(21):5328-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8221669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 1995 Dec 11;23(23):4878-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8532532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1997 Sep;71(9):6887-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9261415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genes Dev. 1998 Jul 1;12(13):2061-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9649509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 1999 Feb;19(2):959-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9891032</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J STD AIDS. 2006 Jul;17(7):448-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16820073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dermatolog Treat. 2006;17(3):179-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16854762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Virol. 2006 Oct;151(10):1961-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16710631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2006 Nov 10;314(5801):997-1001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17038589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Virol. 2006 Dec;151(12):2461-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16773233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2007 Sep;27(3):370-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17892846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2007 Nov;46 Suppl 3:45-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17973891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Sci. 2008 Mar;99(3):467-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18190617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18354839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug News Perspect. 2008 Mar;21(2):69-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18389099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2008 Aug 15;181(4):2694-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18684960</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2008 Dec 17;27(24):3311-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19008854</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2009 Feb 20;384(2):260-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19135222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine Growth Factor Rev. 2009 Aug;20(4):283-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19651532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Interferon Cytokine Res. 2009 Sep;29(9):629-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19715460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Oncol. 2009 Dec;35(6):1493-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19885573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 1999 Apr;19(4):2465-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10082512</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 1999 Sep 15;18(18):5028-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10487755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Feb 15;65(4):1394-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15735026</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>